Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Journal of Neuro-Oncology
|
March 9, 2019
Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial
Nadine M Richard, Lori J Bernstein, Warren P Mason, et al.
Journal of Neuro-Oncology
|
January 29, 2014
Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression
Mairéad G McNamara, Zarnie Lwin, Haiyan Jiang, et al.
Neuro-Oncology Practice
|
March 27, 2023
Review of 20 years of adult medulloblastoma treatment: Chemotherapy prescription trends and survival
Marissa Sherwood, Seth Climans, Ronald Ramos, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
April 11, 2014
Glioblastoma treatment in the elderly in the temozolomide therapy era
Linda Coate, Mairéad G McNamara, Zarnie Lwin, et al.
Neuro-Oncology Practice
|
November 18, 2024
Focal leptomeningeal vascular anomalies on brain MRI: A mimic of leptomeningeal metastatic disease
Alexandre Boutet, Mikail Malik, Andrew Z Yang, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 11, 2017
Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas
Mairéad G McNamara, Haiyan Jiang, Mary Jane Lim-Fat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
Martin J B Taphoorn, Roger Henriksson, Andrew Bottomley, et al.
Neuro-Oncology
|
March 4, 2011
Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes
Kim Edelstein, Brenda J Spiegler, Sharon Fung, et al.
Neuro-Oncology
|
August 21, 2014
Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma
David A Reardon, Louis B Nabors, Warren P Mason, et al.
Molecular Cancer Therapeutics
|
November 28, 2023
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma
Cha Len Lee, Grainne M O'Kane, Warren P Mason, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Journal of Neuro-Oncology
|
March 9, 2019
Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial
Nadine M Richard, Lori J Bernstein, Warren P Mason, et al.
Journal of Neuro-Oncology
|
January 29, 2014
Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression
Mairéad G McNamara, Zarnie Lwin, Haiyan Jiang, et al.
Neuro-Oncology Practice
|
March 27, 2023
Review of 20 years of adult medulloblastoma treatment: Chemotherapy prescription trends and survival
Marissa Sherwood, Seth Climans, Ronald Ramos, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
April 11, 2014
Glioblastoma treatment in the elderly in the temozolomide therapy era
Linda Coate, Mairéad G McNamara, Zarnie Lwin, et al.
Neuro-Oncology Practice
|
November 18, 2024
Focal leptomeningeal vascular anomalies on brain MRI: A mimic of leptomeningeal metastatic disease
Alexandre Boutet, Mikail Malik, Andrew Z Yang, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 11, 2017
Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas
Mairéad G McNamara, Haiyan Jiang, Mary Jane Lim-Fat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
Martin J B Taphoorn, Roger Henriksson, Andrew Bottomley, et al.
Neuro-Oncology
|
March 4, 2011
Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes
Kim Edelstein, Brenda J Spiegler, Sharon Fung, et al.
Neuro-Oncology
|
August 21, 2014
Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma
David A Reardon, Louis B Nabors, Warren P Mason, et al.
Molecular Cancer Therapeutics
|
November 28, 2023
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma
Cha Len Lee, Grainne M O'Kane, Warren P Mason, et al.
Page
of 12